Yao Liang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Systemic Lupus Erythematosus

Ejection Fraction

Top Venues

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yao Liang, Osamu Maeda, Yuichi Ando
Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors. Japanese journal of clinical oncology (2024)
Yao Liang, Osamu Maeda, Chiaki Kondo, Kazuki Nishida, Yuichi Ando
Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma. PloS one 19 (7) (2024)
Yao Liang, Osamu Maeda, Chiaki Kondo, Kazuki Nishida, Yuichi Ando
Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma. PloS one 19 (7) (2024)
Yao Liang, Osamu Maeda, Chiaki Kondo, Kazuki Nishida, Yuichi Ando
Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma. PloS one 19 (7) (2024)
Yao Liang, Osamu Maeda, Yuichi Ando
Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors. Japanese journal of clinical oncology 54 (4) (2024)